1. Metformin in Lung Cancer: Review of in Vitro and in Vivo Animal Studies
    Michael Yousef et al, 2017, Cancers CrossRef
  2. Kallistatin suppresses cancer development by multi-factorial actions
    Julie Chao et al, 2017, Critical Reviews in Oncology/Hematology CrossRef
  3. Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model
    Alison M. Heffer et al, 2020, PLOS ONE CrossRef
  4. Metformin Suppresses Stemness of Non-Small-Cell Lung Cancer Induced by Paclitaxel through FOXO3a
    Zhimin Tang et al, 2023, International Journal of Molecular Sciences CrossRef
  5. Metformin reverses the resistance mechanism of lung adenocarcinoma cells that knocks down the Nrf2 gene
    Jiacui Zhang et al, 2018, Oncology Letters CrossRef
  6. Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma
    Akira Nakayama et al, 2016, International Journal of Oncology CrossRef
  7. Simultaneous Detection of Autophagy and Epithelial to Mesenchymal Transition in the Non-small Cell Lung Cancer Cells
    Javad Alizadeh et al, 2017, Autophagy in Differentiation and Tissue Maintenance CrossRef
  8. Chemical biology of salinomycin
    Antoine Versini et al, 2018, Tetrahedron CrossRef
  9. A comprehensive review of salinomycin derivatives as potent anticancer and anti-CSCs agents
    Michał Antoszczak, 2019, European Journal of Medicinal Chemistry CrossRef
  10. The Therapeutic Activities of Metformin: Focus on the Nrf2 Signaling Pathway and Oxidative Stress Amelioration
    Gholamreza Bazmandegan et al, 2023, Current Molecular Pharmacology CrossRef
  11. TGFΒ-induced transcription in cancer
    Gaia Cantelli et al, 2017, Seminars in Cancer Biology CrossRef

  12. Salinomycin and Sulforaphane Exerted Synergistic Antiproliferative and Proapoptotic Effects on Colorectal Cancer Cells by Inhibiting the PI3K/Akt Signaling Pathway in vitro and in vivo


    Fang Liu et al, 2020, OncoTargets and Therapy CrossRef
  13. miR-768-3p is involved in the proliferation, invasion and migration of non-small cell lung carcinomas
    Zuozhou Xie et al, 2017, International Journal of Oncology CrossRef
  14. Metformin in Cervical Cancer: Metabolic Reprogramming
    Malgorzata Tyszka-Czochara et al, 2019, Metformin [Working Title] CrossRef
  15. Autophagy modulates transforming growth factor beta 1 induced epithelial to mesenchymal transition in non-small cell lung cancer cells
    Javad Alizadeh et al, 2018, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
  16. Animal models and in vivo investigations for drug repurposing in lung cancer
    Hsuen-Wen Kate Chang et al, 2020, Drug Repurposing in Cancer Therapy CrossRef
  17. Effects of bradykinin on TGF‑β1‑induced epithelial‑mesenchymal transition in ARPE‑19 cells
    Qingquan Wei et al, 2018, Molecular Medicine Reports CrossRef
  18. Salinomycin: A new paradigm in cancer therapy
    Jayant Dewangan et al, 2017, Tumor Biology CrossRef
  19. A medicinal chemistry perspective on salinomycin as a potent anticancer and anti-CSCs agent
    Michał Antoszczak, 2019, European Journal of Medicinal Chemistry CrossRef